Health care stocks were steady to higher premarket Wednesday, with The Health Care Select Sector SPDR Fund (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) unchanged.
HealthEquity (HQY) shares were down 15% after the company reported overnight fiscal Q4 non-GAAP earnings that trailed analysts' estimates.
Hutchmed (HCM) and Innovent Biologics said late Tuesday that a phase II/III clinical trial of fruquintinib in combination with sintilimab as a second-line treatment for renal cell carcinoma in China met its primary endpoint of progression free survival. Hutchmed stock was 3.2% higher pre-bell Wednesday.
Concentra (CON) shares were up 3.6% after the company said overnight it opened a new medical center in Waukegan, Illinois.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。